Cargando…
Anti-Insulin Receptor Autoantibodies Are Not Required for Type 2 Diabetes Pathogenesis in NZL/Lt Mice, a New Zealand Obese (NZO)-Derived Mouse Strain
The New Zealand obese (NZO) mouse strain shares with the related New Zealand black (NZB) strain a number of immunophenotypic traits. Among these is a high proportion of B-1 B lymphocytes, a subset associated with autoantibody production. Approximately 50% of NZO/HlLt males develop a chronic insulin-...
Autores principales: | McInerney, Marcia F., Najjar, Sonia M., Brickley, Deanna, Lutzke, Mary, Abou-Rjaily, George A., Reifsnyder, Peter, Haskell, Bradford D., Flurkey, Kevin, Zhang, Ying-Jian, Pietropaolo, Susan L., Pietropaolo, Massimo, Byers, James P., Leiter, Edward H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478629/ https://www.ncbi.nlm.nih.gov/pubmed/15512785 http://dx.doi.org/10.1080/15438600490478029 |
Ejemplares similares
-
Comparison of Two New Mouse Models of Polygenic Type 2 Diabetes at the Jackson Laboratory, NONcNZO10Lt/J and TALLYHO/JngJ
por: Leiter, Edward H., et al.
Publicado: (2013) -
Rapamycin Ameliorates Nephropathy despite Elevating Hyperglycemia in a Polygenic Mouse Model of Type 2 Diabetes, NONcNZO10/LtJ
por: Reifsnyder, Peter C., et al.
Publicado: (2014) -
Correction: Rapamycin Ameliorates Nephropathy despite Elevating Hyperglycemia in a Polygenic Mouse Model of Type 2 Diabetes, NONcNZO10/LtJ
Publicado: (2015) -
Design and Pharmacodynamics of Recombinant Fungus Defensin NZL with Improved Activity against Staphylococcus hyicus In Vitro and In Vivo
por: Liu, He, et al.
Publicado: (2021) -
GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
por: Schwenk, Robert W., et al.
Publicado: (2014)